{"id":1992,"date":"2026-05-12T12:00:48","date_gmt":"2026-05-12T12:00:48","guid":{"rendered":"https:\/\/wickedsister.evit.com.au\/index.php\/2026\/05\/12\/privosegtor-optic-neuritis-clinical-trial-design-gains-fda-agreement\/"},"modified":"2026-05-12T12:00:48","modified_gmt":"2026-05-12T12:00:48","slug":"privosegtor-optic-neuritis-clinical-trial-design-gains-fda-agreement","status":"publish","type":"post","link":"https:\/\/wickedsister.evit.com.au\/index.php\/2026\/05\/12\/privosegtor-optic-neuritis-clinical-trial-design-gains-fda-agreement\/","title":{"rendered":"Privosegtor optic neuritis clinical trial design gains FDA agreement"},"content":{"rendered":"<p><a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/05\/12\/privosegtor-optic-neuritis-clinical-trial-design-gains-fda-agreement\/\" title=\"Privosegtor optic neuritis clinical trial design gains FDA agreement\" rel=\"nofollow\"><img loading=\"lazy\" decoding=\"async\" width=\"770\" height=\"800\" src=\"https:\/\/multiplesclerosisnewstoday.com\/wp-content\/uploads\/2026\/05\/fda-2-770x800.jpg\" class=\"webfeedsFeaturedVisual wp-post-image\" alt=\"The letters FDA are shown in a speech bubble with a megaphone isolated on a blank background.\" style=\"margin: auto;margin-bottom: 15px;max-width: 100%\" data-wp-pid=\"162010\" \/><\/a><\/p>\n<p>The U.S. Food and Drug Administration (FDA) has formally agreed that the design and planned analysis of an upcoming Phase 3 trial testing privosegtor in people with optic neuritis could support a future application seeking the therapy\u2019s approval if the trial succeeds. Optic neuritis, or inflammation of the optic nerve that carries information between the [&#8230;]<\/p>\n<p>The post <a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/05\/12\/privosegtor-optic-neuritis-clinical-trial-design-gains-fda-agreement\/\">Privosegtor optic neuritis clinical trial design gains FDA agreement<\/a> appeared first on <a href=\"https:\/\/multiplesclerosisnewstoday.com\">Multiple Sclerosis News Today<\/a>.<\/p>\n<p><em>Source: <a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/05\/12\/privosegtor-optic-neuritis-clinical-trial-design-gains-fda-agreement\/\" rel=\"nofollow noopener\" target=\"_blank\">multiplesclerosisnewstoday.com<\/a><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The U.S. Food and Drug Administration (FDA) has formally agreed that the design and planned analysis of an upcoming Phase 3 trial testing privosegtor in people with optic neuritis could support a future application seeking the therapy\u2019s approval if the trial succeeds. Optic neuritis, or&hellip;<\/p>\n","protected":false},"author":0,"featured_media":1993,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[11,15,9,8,13,14,12,10],"class_list":["post-1992","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-multiple-sclerosis-research","tag-brain-repair","tag-marburg-type-ms","tag-ms","tag-multiple-sclerosis","tag-myelin","tag-neuroregeneration","tag-oligodendrocyte","tag-remyelination"],"_links":{"self":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/1992","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/comments?post=1992"}],"version-history":[{"count":0,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/1992\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media\/1993"}],"wp:attachment":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media?parent=1992"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/categories?post=1992"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/tags?post=1992"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}